Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PSATZ (prostate specific antigen adjusted for the transition zone volume)]

H Maeda1, K Okubo, Y Arai

  • 1Department of Urology, Kurashiki Central Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 29, 1998
PubMed
Summary

Prostate specific antigen adjusted for transition zone volume (PSATZ) shows promise for detecting prostate cancer in men with intermediate PSA levels. This indicator may improve early diagnosis, though further research is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydroxyl radical production by H2O2 plus Cu,Zn-superoxide dismutase reflects the activity of free copper released from the oxidatively damaged enzyme.

The Journal of biological chemistry·1992
Same author

Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture.

Journal of cardiovascular pharmacology·1992
Same author

Inhibition of mite protease (Df-protease) with protease inhibitors.

Biochemistry international·1992
Same author

[Pharmacokinetic and clinical studies of cefprozil fine granules in children].

The Japanese journal of antibiotics·1992
Same author

[A case of primary alveolar hypoventilation syndrome with a good response to nocturnal low-flow oxygen inhalation and negative pressure ventilation].

Nihon Kyobu Shikkan Gakkai zasshi·1992
Same author

Microvasculature of normal and hydropic labyrinth.

Scanning microscopy·1992

Area of Science:

  • Urology
  • Oncology
  • Biomarker Research

Context:

  • Prostate cancer diagnosis often relies on prostate specific antigen (PSA) levels.
  • Intermediate PSA levels (4.1-10.0 ng/ml) present diagnostic challenges.
  • Distinguishing benign conditions from early prostate cancer is crucial.

Purpose:

  • To review the diagnostic performance of prostate specific antigen adjusted for transition zone volume (PSATZ) for prostate cancer detection.
  • To compare PSATZ with traditional markers like PSA and prostate specific antigen density.
  • To evaluate PSATZ utility in patients with intermediate PSA levels.

Summary:

  • PSATZ, calculated as PSA divided by transition zone volume, demonstrates potential as a diagnostic indicator.
  • PSATZ may enhance prostate cancer detection in men with intermediate PSA levels, particularly with normal digital rectal examinations.

Related Experiment Videos

  • Existing studies support the efficacy of PSATZ, aligning with current findings.

    • Impact:

    • PSATZ could refine diagnostic strategies for prostate cancer, improving accuracy in ambiguous cases.
    • Further investigation is required to ascertain PSATZ's cost-effectiveness and superiority over emerging biomarkers like the free-to-total PSA ratio.
    • Enhanced diagnostic tools are vital for timely and appropriate patient management.